EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Distinct designs, complementary strategies: Tendyne and SAPIEN M3 in transcatheter mitral valve replacement

Zhaoyang Ye, Stephanie Sellers, David Meier, Tim Attmann, Xiling Zhang, Thomas Puehler, Nina Pommert, Jacob Voran, Won Kim, Gregor Warnecke, Derk Frank, Georg Lutter

Frontiers in Cardiovascular Medicine · 11.11.2026 · 13

DOI: 10.3389/fcvm.2026.1966140 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 11.11.2026. Verfasst von Zhaoyang Ye und 11 weiteren Autor:innen. Die Arbeit nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Transcatheter mitral valve replacement (TMVR) has emerged as a transcatheter treatment option for selected patients with mitral regurgitation (MR) who are unsuitable for surgery or transcatheter edge-to-edge repair. Among dedicated TMVR devices, the Tendyne and SAPIEN M3 systems are the two clinically approved tech platforms with CE Mark and FDA approval. We comprehensively dissect their distinct design features, procedural characteristics, clinical outcomes, and associated complication profiles. Furthermore, we evaluate their respective patient selection criteria and long-term prognostic implications to facilitate evidence-based clinical decision-making for patients with severe MR. Beyond current metallic prostheses, this review extends to the future horizons of TMVR, specifically highlighting the emerging paradigm of tissue-engineered valvular stents and biodegradable scaffolds as potential solutions to overcome current limitations in prosthetic durability and biocompatibility.

Zitieren

APA

Ye, Z., Sellers, S., Meier, D., Attmann, T., Zhang, X., Puehler, T., Pommert, N., Voran, J., Kim, W., Warnecke, G., Frank, D., & Lutter, G. (2026). Distinct designs, complementary strategies: Tendyne and SAPIEN M3 in transcatheter mitral valve replacement. Frontiers in Cardiovascular Medicine, 13. https://doi.org/10.3389/fcvm.2026.1966140

Vancouver

Ye Z, Sellers S, Meier D, Attmann T, Zhang X, Puehler T, et al. Distinct designs, complementary strategies: Tendyne and SAPIEN M3 in transcatheter mitral valve replacement. Frontiers in Cardiovascular Medicine. 2026;13. doi:10.3389/fcvm.2026.1966140

BibTeX
@article{Ye2026,
  author = {Ye, Zhaoyang and Sellers, Stephanie and Meier, David and Attmann, Tim and Zhang, Xiling and Puehler, Thomas and Pommert, Nina and Voran, Jacob and Kim, Won and Warnecke, Gregor and Frank, Derk and Lutter, Georg},
  title = {Distinct designs, complementary strategies: Tendyne and SAPIEN M3 in transcatheter mitral valve replacement},
  journal = {Frontiers in Cardiovascular Medicine},
  year = {2026},
  volume = {13},
  doi = {10.3389/fcvm.2026.1966140}
}
Kostenlos starten →